Do High-Risk pregnant women know the warning signs of preeclampsia?

NCT ID NCT07805239

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 04, 2026 · Last updated Sep 04, 2026

Summary

This study asks whether pregnant women at high risk for preeclampsia understand the condition, its warning signs, and its risk factors. Researchers will interview 160 women at Sohag University Hospital using a standardized questionnaire. The goal is to identify gaps in knowledge and the social or demographic factors linked to lower awareness. Findings could point toward better education for early detection and timely care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Questionnaire
What this could lead to
If awareness gaps are found, this could guide education programs to help high-risk pregnant women recognize preeclampsia warning signs earlier.
What could go wrong
This is a single-hospital survey, so results may not apply to other regions. It measures knowledge, not whether better awareness actually prevents complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 160 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Sohag University Hospital at the Obstetric and Gynecology department including admitted inpatient and those attending outpatient clinic .

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Pregnant women aged 18 years or older. 2. women at high risk of PE ( previous history of PE , Diabetes , chronic hypertension , kidney disease , Autoimmune disorders as Antiphospholipid syndrome ). 3. Ability to communicate effectively and provide informed consent, with no cognitive or psychiatric conditions that would interfere with participation or questionnaire completion. Exclusion Criteria: 1. Women with severe medical or obstetric emergencies requiring immediate management at the time of data collection. 2. Women with cognitive impairment, severe psychiatric illness, or communication difficulties that prevent reliable completion of the questionnaire. 3. Incomplete questionnaire responses. \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Preeclampsia awarness are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.